BMP-7 helps reduce inflammation and cell death in diabetic heart and muscle
BMP-7 Modulates Inflammation induced cell death in Diabetic Cardiac and Skeletal Muscle
This study is looking at how a protein called BMP-7 might help reduce inflammation and protect the heart and muscles in people with diabetes, with the goal of improving their overall health and function.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Central Florida NIH-funded |
| Lab location | 1 site (Orlando, United States) |
| Project ID | NIH-10242150 on NIH RePORTER |
What this research studies
This research investigates how BMP-7, a protein, can reduce inflammation and cell death in the heart and skeletal muscles of diabetic patients. The study aims to understand the role of inflammation-induced cell death, known as pyroptosis, in diabetes-related complications. By treating diabetic models with BMP-7, the researchers hope to promote the development of anti-inflammatory cells and improve overall muscle and heart function. The approach includes examining the effects of BMP-7 on inflammatory markers and cell death pathways in diabetic conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with diabetes who are experiencing complications related to heart and skeletal muscle function.
Not a fit: Patients without diabetes or those whose conditions are not related to inflammation-induced cell death may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve heart and muscle health in diabetic patients.
How similar studies have performed: Previous research has shown promising results with BMP-7 in reducing inflammation and improving organ function, suggesting potential success for this approach.
Where this research is happening
Orlando, United States
- University of Central Florida — Orlando, United States (Active)
Researchers
- Principal investigator: Singla, Dinender Kumar — University of Central Florida
- Study coordinator: Singla, Dinender Kumar
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.